POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No61/2021
Date of issue:2021-09-02
Short name of the issuer
SOPHARMA AD
Subject
Notification under Art. 111 para. 6 of LPOS for repurchase of shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, September 2, 2021 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para. 6 of LPOS and in connection with a decision of the General Meeting of the company held on February 23, 2018 and a decision of the Board of Directors of September 2, 2021, “Sopharma” AD notifies that the company intends to buy its own shares in the restriction under Art. 111 para. 5 of LPOS, as follows: - Number of shares subject to repurchase - up to 250,000 (two hundred and fifty thousand) shares; - Minimum repurchase price - not lower than the nominal value per share of the company's capital; - Maximum repurchase price - BGN 5,50 per share of the company's capital; - Repurchase date: September 3, 2021; - Licensed investment intermediary who has been given the purchase order - "First Financial Brokerage House" ООD.
Annexes
FileDescription
SFA_2021_repurchase_espi.pdfNotification under Art. 111 para. 6 of LPOS for repurchase of shares
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2021-09-02Ognian DonevExectuive Director
SFA_2021_repurchase_espi.pdf